WEEKLY NEWSLETTER

Free Healthy Living Email Newsletter
Get the latest health, fitness, anti-aging, and nutrition news, plus special offers, insights and updates from Health.com!
Condition Center

Colorectal Cancer

Colorectal cancer starts in the colon (large intestine) or rectum. The risk of colorectal cancer goes up as you get older (90% of cases occur in people over 50), and if you eat a meat-heavy diet, smoke, or have a family history of the cancer. Colorectal cancer symptoms include pain, blood in the stool, and a change in bowel habits. Routine screening for colorectal cancer is recommended starting at age 50—or even sooner for those with risk factors.

Colorectal Cancer News

  • Americans’ Risk of Dying From Cancer Is Falling, CDC Finds

    By Steven ReinbergHealthDay Reporter THURSDAY, July 2, 2015 (HealthDay News) — The risk that any one American will die from cancer — the cancer death rate — is going down, regardless of sex or race, a new government study reports. However, because the United States has a growing aging population, the overall number of people dying from [...]

  • The Doctor Who Does Your Colonoscopy Matters

    The doctor performing your colonoscopy makes a difference in whether you’ll develop colon cancer or die from it, a new study finds.

  • Smoking Blamed for Half of Deaths From Major Cancers in People Over 35

    By Steven ReinbergHealthDay Reporter MONDAY, June 15, 2015 (HealthDay News) — About half of U.S. deaths caused by certain cancers — including lung, colon and pancreatic tumors — can be attributed to smoking, a new American Cancer Society study estimates. In 2011, nearly half of the almost 346,000 deaths from 12 cancers in people 35 and older [...]

  • More People Are Getting Colon Cancer Screenings After Obamacare

    The Affordable Care Act, often called “Obamacare,” may have helped boost rates of colon cancer screening among poorer Americans, a new study suggests.

  • Gene Test May Predict Success of Cancer Drug in Certain Patients

    FRIDAY, May 29, 2015 (HealthDay News) — The first genetic “marker” — or signal — to predict response to the cancer drug Keytruda (pembrolizumab) has been identified by researchers. The marker — mismatch repair (MMR) deficiency — predicted responses to the drug in patients with several different types of cancer, the study authors said. Among patients with [...]

WEEKLY NEWSLETTER

Free Healthy Living Email Newsletter
Get the latest health, fitness, anti-aging, and nutrition news, plus special offers, insights and updates from Health.com!
Advertisement
Health Headlines from Our Partners